Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chattanooga, TN
NPI
1376663294
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1726 Gunbarrel Rd Ste 100
Chattanooga, TN, 37421
Phone (423) 954-9010
Groups this clinician bills Medicare through
Medicare paid, 2024
$167K
6,115 services
Medicare patients, 2024
756
Average age 73
Drug cost, 2024
$3.0M
7,288 prescriptions
Company payments, 2025
$2,424
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asma S Khan was code 99214 (office e&m - established), 1,100 times for 662 patients. In total Asma S Khan billed 6,115 services in 39 codes, and Medicare paid $167K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,100 | 662 | $89.49 | $98K |
| 83036 Blood Count | Office | 678 | 426 | $9.29 | $6,297 |
| 36415 Venipuncture Blood Collection | Office | 635 | 413 | $8.48 | $5,386 |
| 84443 Clinical Chemistry | Office | 547 | 373 | $16.26 | $8,896 |
| 84439 Clinical Chemistry | Office | 405 | 263 | $8.80 | $3,563 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 401 | 335 | $12.90 | $5,172 |
| 95251 Test - Miscellaneous | Office | 351 | 216 | $25.66 | $9,006 |
| 80053 Clinical Chemistry | Office | 330 | 247 | $10.12 | $3,341 |
| 80061 Clinical Chemistry | Office | 203 | 168 | $12.82 | $2,603 |
| 82043 Clinical Chemistry | Office | 175 | 147 | $5.51 | $964 |
| 82570 Clinical Chemistry | Office | 174 | 147 | $4.94 | $860 |
| 82306 Clinical Chemistry | Office | 139 | 96 | $28.45 | $3,955 |
| 99204 Office E&M - New | Office | 100 | 100 | $112.83 | $11K |
| 84481 Clinical Chemistry | Office | 77 | 53 | $16.60 | $1,278 |
| 80048 Clinical Chemistry | Office | 31 | 23 | $8.02 | $249 |
By year: 2022 $206K for 8,844 services; 2023 $214K for 10,338 services; 2024 $167K for 6,115 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 678 | 426 | $9.29 | $6,297 |
| 36415 Venipuncture Blood Collection | 635 | 413 | $8.48 | $5,386 |
| 84443 Clinical Chemistry | 547 | 373 | $16.26 | $8,896 |
| 84439 Clinical Chemistry | 405 | 263 | $8.80 | $3,563 |
| 80053 Clinical Chemistry | 330 | 247 | $10.12 | $3,341 |
| 80061 Clinical Chemistry | 203 | 168 | $12.82 | $2,603 |
| 82043 Clinical Chemistry | 175 | 147 | $5.51 | $964 |
| 82570 Clinical Chemistry | 174 | 147 | $4.94 | $860 |
| 82306 Clinical Chemistry | 139 | 96 | $28.45 | $3,955 |
| 84481 Clinical Chemistry | 77 | 53 | $16.60 | $1,278 |
Medicare prescription drug claims, 2024
In 2024, the drug Asma S Khan prescribed most often to Medicare patients was Levothyroxine Sodium, with 921 prescriptions and refills. In total Asma S Khan wrote 7,288 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 921 | 2,448 | 263 | $7,775 |
| Ozempic Semaglutide | 487 | 734 | 132 | $669K |
| Mounjaro Tirzepatide | 292 | 366 | 75 | $374K |
| Novolog Flexpen Insulin Aspart | 271 | 496 | 93 | $96K |
| Metformin Hcl Er Metformin Hcl | 254 | 728 | 93 | $3,066 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 235 | 539 | 101 | $42K |
| Methimazole Generic | 218 | 537 | 56 | $3,039 |
| Metformin Hcl Generic | 214 | 583 | 82 | $1,349 |
| Synthroid Levothyroxine Sodium | 194 | 471 | 55 | $16K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 171 | 451 | 72 | $20K |
| Atorvastatin Calcium Generic | 163 | 449 | 51 | $2,187 |
| Tresiba Flextouch U-100 Insulin Degludec | 163 | 427 | 62 | $136K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 157 | 341 | 47 | $122K |
| Farxiga Dapagliflozin Propanediol | 151 | 295 | 42 | $157K |
| Trulicity Dulaglutide | 127 | 175 | 29 | $165K |
Brand drugs: 3,737 claims; generic drugs: 2,974 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asma S Khan $2,424 ($2,424 in general payments such as food, travel and fees) from 27 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $247.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $247 |
| Lilly USA, LLC LLY | 18 | $246 |
| Novo Nordisk Inc NVO | 12 | $215 |
| Ascendis Pharma Endocrinology Inc ASND | 11 | $192 |
| Abbott Laboratories ABT | 10 | $170 |
| CeQur Corporation | 1 | $145 |
| Dexcom, Inc. DXCM | 5 | $123 |
| Chiesi USA, Inc. | 2 | $115 |
| Sequel Med Tech, LLC | 5 | $100 |
| Medtronic, Inc. MDT | 2 | $89.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.